KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
The Wall Street Journal, United States - 25 July 2012
China will expand use of a value-added tax to cover 10 more cities and provinces, in yet-another trial step to boost growth and promote economic restructuring ... Read the full article
Related links
RSS feeds